ArticleEJHaem2024

Aplastic anemia triggered by the Bruton tyrosine kinase inhibitor acalabrutinib in two patients with mantle cell lymphoma - A case report.

Anna Nikkarinen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.